GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Blueberries Medical Corp (OTCPK:BBRRF) » Definitions » Cash Ratio

Blueberries Medical (Blueberries Medical) Cash Ratio : 1.78 (As of Dec. 2023)


View and export this data going back to 2019. Start your Free Trial

What is Blueberries Medical Cash Ratio?

The Cash Ratio measures a company’s ability to meet its short-term obligations with cash and near-cash resources. It is calculated as a company's Cash, Cash Equivalents, Marketable Securities divides by its Total Current Liabilities. Blueberries Medical's Cash Ratio for the quarter that ended in Dec. 2023 was 1.78.

Blueberries Medical has a Cash Ratio of 1.78. It generally indicates that the company is able to cover all short-term debt and still have cash remaining.

The historical rank and industry rank for Blueberries Medical's Cash Ratio or its related term are showing as below:

BBRRF' s Cash Ratio Range Over the Past 10 Years
Min: 0.01   Med: 0.75   Max: 11.47
Current: 1.78

During the past 11 years, Blueberries Medical's highest Cash Ratio was 11.47. The lowest was 0.01. And the median was 0.75.

BBRRF's Cash Ratio is ranked better than
76.12% of 980 companies
in the Drug Manufacturers industry
Industry Median: 0.59 vs BBRRF: 1.78

Blueberries Medical Cash Ratio Historical Data

The historical data trend for Blueberries Medical's Cash Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Blueberries Medical Cash Ratio Chart

Blueberries Medical Annual Data
Trend Mar14 Mar15 Mar16 Mar17 Mar18 Dec19 Dec20 Dec21 Dec22 Dec23
Cash Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 2.44 0.15 0.69 0.81 1.78

Blueberries Medical Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Cash Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.81 0.50 0.39 0.29 1.78

Competitive Comparison of Blueberries Medical's Cash Ratio

For the Drug Manufacturers - Specialty & Generic subindustry, Blueberries Medical's Cash Ratio, along with its competitors' market caps and Cash Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Blueberries Medical's Cash Ratio Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Blueberries Medical's Cash Ratio distribution charts can be found below:

* The bar in red indicates where Blueberries Medical's Cash Ratio falls into.



Blueberries Medical Cash Ratio Calculation

The Cash Ratio measures a company's ability to meet its short-term obligations with its cash and near-cash resources.

Blueberries Medical's Cash Ratio for the fiscal year that ended in Dec. 2023 is calculated as:

Cash Ratio (A: Dec. 2023 )=Cash, Cash Equivalents, Marketable Securities/Total Current Liabilities
=0.61/0.343
=1.78

Blueberries Medical's Cash Ratio for the quarter that ended in Dec. 2023 is calculated as:

Cash Ratio (Q: Dec. 2023 )=Cash, Cash Equivalents, Marketable Securities/Total Current Liabilities
=0.61/0.343
=1.78

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Blueberries Medical  (OTCPK:BBRRF) Cash Ratio Explanation

The cash ratio is more conservative than other liquidity ratios, such as Quick Ratio and Current Ratio, because it only considers a company's most liquid resources. The numerator of cash ratio only considers Cash, Cash Equivalents and marketable securities. Other current assets, such as accounts receivable and inventories, are not included. The rationale is that these assets may require time to be transformed into cash, and the amount of money received is also uncertain.

The cash ratio shows a company’s ability to pay all current liabilities immediately without selling or liquidating other assets. Generally speaking, a higher cash ratio suggests the company has a stronger ability to cover its short-term debt. However, a high cash ratio could also indicate inefficient management: the company is inefficient in making full utilization of cash to invest protential profitable project. It may also suggest that the company is not confident about future profitability.

In general, the higher the cash ratio, the better the company's liquidity position.


Blueberries Medical Cash Ratio Related Terms

Thank you for viewing the detailed overview of Blueberries Medical's Cash Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Blueberries Medical (Blueberries Medical) Business Description

Traded in Other Exchanges
Address
8500 West Georgia Street, Suite 2200, Vancouve, BC, CAN, V6C 3E8
Blueberries Medical Corp is a licensed producer of psychoactive and non-psychoactive cannabis by-products in Colombia. It cultivates, produces, and distributes cannabidiol (CBD) and THC (tetrahydrocannabinol) based medical cannabis domestically as well as internationally. It generates all of its revenues from Colombia.

Blueberries Medical (Blueberries Medical) Headlines

From GuruFocus

Blueberries Medical Reports 2020 Financial Results

By Marketwired Marketwired 04-30-2021